FDA’s medical review departments remain untouched (for now) by Musk’s cuts

Zachary Brennan

Senior Editor

Since President Trump took office, Elon Musk’s Department of Government Efficiency has laid off thousands of government workers through broad, sudden cuts — some later reversed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

FDA’s medical review departments remain untouched (for now) by Musk’s cuts

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

Zealand partners with Roche on its amylin analog in a deal worth up to $5.3B

Arvinas, Pfizer’s PROTAC data fall short of hype in breast cancer

Corrected: Merck opens billion-dollar US facility to make Gardasil

Bristol Myers buys out cell therapy partner 2seventy bio

Gilead plans to skip from Phase 1 to Phase 3 with once-yearly HIV prevention drug

Obesity drug development—still room to grow

FDA’s med­ical re­view de­part­ments re­main un­touched (for now) by Musk’s cuts

Senior Editor

Sign up to read this article for free.

Gondolabio

Palo Alto, CA, USA

FDA’s medical review departments remain untouched (for now) by Musk’s cuts